Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 ADME and pharmacokinetics study of oral [14C]LTP001 in healthy male participants
NL-OMON59695Phase 1Completed
- Sponsor
- Novartis
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of LTP001, sponsored by Novartis. Primary endpoint: Primary endpoint(s). Started Mar 2026; status: completed.
02
Drugs
LTP001
Beyond the preview
Go deeper on NL-OMON59695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59695.